Mitoepigenetics and hepatocellular carcinoma

María Guadalupe Lozano-Rosas , Enrique Chávez , Alejandro Rusbel Aparicio-Cadena , Gabriela Velasco-Loyden , Victoria Chagoya de Sánchez

Hepatoma Research ›› 2018, Vol. 4 : 19

PDF
Hepatoma Research ›› 2018, Vol. 4:19 DOI: 10.20517/2394-5079.2018.48
Review
Review

Mitoepigenetics and hepatocellular carcinoma

Author information +
History +
PDF

Abstract

Mitochondria are the center of energy production in eukaryotic cells and are crucial for several cellular processes. Dysfunctional mitochondria have been associated with cancer progression. Mitochondria contain their own circular DNA (mtDNA), which codes for 13 proteins, 2rRNA, 22tRNA and non-coding RNAs. Recent evidence showed the presence of 5-methylcytosine and 5-hydroximethylcytosine in mtDNA suggesting that the level of gene expression could be modulated like a nuclear DNA by direct epigenetic modifications. Mitoepigenetics is a bidirectional phenomenon in the epigenetic regulation of mitochondrial genes encoded in both the nucleus and the mitochondrion. This process is affected by SAM-mediated methylation and hydroxymethylation of mtDNA and by nuclear chromatin modulators from mitochondria, such as Acetyl-CoA and NAD+. There is some information about physiological and pathological methylated profiles, but information is scarce for hepatocellular carcinoma (HCC). The aim of this review is to summarize the mitoepigenetic knowledge in HCC already reported so far, through a keywords search in Medline. In addition, the deregulation of energy intermediaries needed for the mitoepigenetic regulation is described. As this is a new area of study, a rigorous analysis and careful interpretation and integration of results are needed.

Keywords

Hepatocellular carcinoma / mitochondrial genome / mitochondrial epigenome / microRNAs

Cite this article

Download citation ▾
María Guadalupe Lozano-Rosas, Enrique Chávez, Alejandro Rusbel Aparicio-Cadena, Gabriela Velasco-Loyden, Victoria Chagoya de Sánchez. Mitoepigenetics and hepatocellular carcinoma. Hepatoma Research, 2018, 4: 19 DOI:10.20517/2394-5079.2018.48

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Cardin R,Bortolami M,Barzon L,Sinigaglia A,Rugge M.Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: an intricate pathway.World J Gastroenterol2014;20:3078-86 PMCID:PMC3964380

[2]

Tu T,Maczurek AE,Di Bartolomeo A,McCaughan GW,Shackel NA.Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development.Int J Mol Sci2014;15:9422-58 PMCID:PMC4100103

[3]

Manev H.Progress in mitochondrial epigenetics.Biomol Concepts2013;4:381-9

[4]

Bellizzi D,Giordano M,Passarino G.Global DNA methylation levels are modulated by mitochondrial DNA variants.Epigenomics2012;4:17-27

[5]

Barbosa IA,Skildum AJ,Oliveira PJ.Mitochondrial remodeling in cancer metabolism and survival: potential for new therapies.Biochim Biophys Acta2012;1826:238-54

[6]

Hernandez-Munoz R.In vivo correlation between liver and blood energy status as evidenced by chronic treatment of carbon tetrachloride and adenosine to rats.Can J Physiol Pharmacol1994;72:1252-6

[7]

Hernandez-Munoz R,Diaz-Munoz M,Lozano J.Alterations of ATP levels and of energy parameters in the blood of alcoholic and nonalcoholic patients with liver damage.Alcohol Clin Exp Res1991;15:500-3

[8]

Chavez E,Dominguez-Lopez M,Rodriguez-Aguilera JR,Tuena de Gomez-Puyou M.Functional, metabolic, and dynamic mitochondrial changes in the rat cirrhosis-hepatocellular carcinoma model and the protective effect of IFC-305.J Pharmacol Exp Ther2017;361:292-302

[9]

Warburg O.On respiratory impairment in cancer cells.Science1956;124:269-70

[10]

Singh KK,Sigala B,Williams J.Mitochondrial DNA determines the cellular response to cancer therapeutic agents.Oncogene1999;18:6641-6

[11]

Modica-Napolitano JS,Singh KK.Mitochondria and human cancer.Curr Mol Med2007;7:121-31

[12]

Modica-Napolitano JS.Mitochondrial dysfunction in cancer.Mitochondrion2004;4:755-62

[13]

Penta JS,Wachsman JT.Mitochondrial DNA in human malignancy.Mutat Res2001;488:119-33

[14]

Graier WF,Malli R.Mitochondria and Ca(2+) signaling: old guests, new functions.Pflugers Arch2007;455:375-96 PMCID:PMC4864527

[15]

Kasahara A.Mitochondria: from cell death executioners to regulators of cell differentiation.Trends Cell Biol2014;24:761-70

[16]

Mposhi A,Faber KN.Regulation of mitochondrial gene expression, the epigenetic enigma.Front Biosci (Landmark Ed)2017;22:1099-113

[17]

Campbell A,Karlin S.Genome signature comparisons among prokaryote, plasmid, and mitochondrial DNA.Proc Natl Acad Sci U S A1999;96:9184-9 PMCID:PMC17754

[18]

Singh KK.Mitochondrial dysfunction is a common phenotype in aging and cancer.Ann N Y Acad Sci2004;1019:260-4

[19]

Schatz G.The protein import system of mitochondria.J Biol Chem1996;271:31763-6

[20]

Wallace DC.Energetics, epigenetics, mitochondrial genetics.Mitochondrion2010;10:12-31 PMCID:PMC3245717

[21]

Wellen KE.A two-way street: reciprocal regulation of metabolism and signalling.Nat Rev Mol Cell Biol2012;13:270-6

[22]

Lu SC.S-adenosylmethionine in liver health, injury, and cancer.Physiol Rev2012;92:1515-42 PMCID:PMC3698976

[23]

Agrimi G,Marobbio CM,Lasorsa FM.Identification of the human mitochondrial S-adenosylmethionine transporter: bacterial expression, reconstitution, functional characterization and tissue distribution.Biochem J2004;379:183-90 PMCID:PMC1224042

[24]

Depeint F,Shangari N,O'Brien PJ.Mitochondrial function and toxicity: role of B vitamins on the one-carbon transfer pathways.Chem Biol Interact2006;163:113-32

[25]

Naviaux RK.Mitochondrial control of epigenetics.Cancer Biol Ther2008;7:1191-3

[26]

Chagoya de Sanchez V,Sanchez L,Yanez L.Twenty-four-hour changes of S-adenosylmethionine, S-adenosylhomocysteine adenosine and their metabolizing enzymes in rat liver; possible physiological significance in phospholipid methylation.Int J Biochem1991;23:1439-43

[27]

van der Wijst MG,Ruiters MH.Experimental mitochondria-targeted DNA methylation identifies GpC methylation, not CpG methylation, as potential regulator of mitochondrial gene expression.Sci Rep2017;7:177 PMCID:PMC5428053

[28]

Karpf AR.Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells.Cancer Res2005;65:8635-9

[29]

Jones PA.Cancer. Death and methylation..Nature2001;409:141, 143-4

[30]

Laird PW.The power and the promise of DNA methylation markers.Nat Rev Cancer2003;3:253-66

[31]

Manev H,Chen H.Mitochondrial DNA: a blind spot in neuroepigenetics.Biomol Concepts2012;3:107-15 PMCID:PMC3359012

[32]

Ferreira A,Sardao VA.Role of mtDNA-related mitoepigenetic phenomena in cancer.Eur J Clin Invest2015;45 Suppl 1:44-9

[33]

Shock LS,Peterson EJ,Taylor SM.DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria.Proc Natl Acad Sci U S A2011;108:3630-5 PMCID:PMC3048134

[34]

Rebelo AP,Moraes CT.In vivo methylation of mtDNA reveals the dynamics of protein-mtDNA interactions.Nucleic Acids Res2009;37:6701-15 PMCID:PMC2777446

[35]

Bellizzi D,Scafone T,Riso V,Passarino G.The control region of mitochondrial DNA shows an unusual CpG and non-CpG methylation pattern.DNA Res2013;20:537-47 PMCID:PMC3859322

[36]

Ghosh S,Scaria V.Comparative analysis of human mitochondrial methylomes shows distinct patterns of epigenetic regulation in mitochondria.Mitochondrion2014;18:58-62

[37]

Metodiev MD,Park CB,Shi Y,Hultenby K,Larsson NG.Methylation of 12S rRNA is necessary for in vivo stability of the small subunit of the mammalian mitochondrial ribosome.Cell Metab2009;9:386-97

[38]

Giordano M,Crocco P,De Rango F,Scafone T,Rose G,Beliizi D.Methylation of the human mitochondrial 12s rRNA gene is correlated with aging.Proceedings of 12th International Congress FISV Congress. Rome, Italy; 2012 Sep 24-27

[39]

Liu B,Chen L,Li S,Zhang X,Bin C.CpG methylation patterns of human mitochondrial DNA.Sci Rep2016;6:23421 PMCID:PMC4800444

[40]

Salminen A,Hiltunen M.Krebs cycle intermediates regulate DNA and histone methylation: epigenetic impact on the aging process.Ageing Res Rev2014;16:45-65

[41]

Ghosh S,Scaria V.Hydroxymethyl cytosine marks in the human mitochondrial genome are dynamic in nature.Mitochondrion2016;27:25-31

[42]

Iacobazzi V,Infantino V.Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool.Mol Genet Metab2013;110:25-34

[43]

Tomasetti M,Neuzil J.MicroRNA regulation of cancer metabolism: role in tumour suppression..Mitochondrion2014;19 Pt A:29-38

[44]

Ameres SL.Diversifying microRNA sequence and function.Nat Rev Mol Cell Biol2013;14:475-88

[45]

Bienertova-Vasku J,Slaby O.The role of microRNAs in mitochondria in cancer.Cancer Lett2013;336:1-7

[46]

Giuliani A,Micolucci L,Procopio AD.Mitochondrial (Dys) function in inflammaging: do mitomiRs influence the energetic, oxidative, and inflammatory status of senescent cells?.Mediators Inflamm2017;2017:2309034

[47]

Das S,Kent OA,Wang R,Raghavachari N,Wheelan SJ,Steenbergen C.Nuclear miRNA regulates the mitochondrial genome in the heart.Circ Res2012;110:1596-603 PMCID:PMC3390752

[48]

Wang JX,Li Q,Wang K,Li YR.miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1.Nat Med2011;17:71-8

[49]

Finley LW.The coordination of nuclear and mitochondrial communication during aging and calorie restriction.Ageing Res Rev2009;8:173-88 PMCID:PMC4702504

[50]

Boland ML,Macleod KF.Mitochondrial dysfunction in cancer.Front Oncol2013;3:292 PMCID:PMC3844930

[51]

Chen J ZB,Lo AW,Chan AW,Ho CY,Lai PB,Ng HK,Huang AL,Ko BC.Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth.Cancer Res2012;72:4138-49

[52]

Barres R,Yan J,Fritz T,Krook A.Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density.Cell Metab2009;10:189-98

[53]

Scarpulla RC.Nuclear control of respiratory gene expression in mammalian cells.J Cell Biochem2006;97:673-83

[54]

Hanaoka S,Tanaka S,Okuda K,Ohta S.Tributyltin induces epigenetic changes and decreases the expression of nuclear respiratory factor-1.Metallomics2018;10:337-45

[55]

Ozawa T.Mitochondrial DNA mutations and age.Ann N Y Acad Sci1998;854:128-54

[56]

Smiraglia DJ,Bistulfi GL,Singh KK.A novel role for mitochondria in regulating epigenetic modification in the nucleus.Cancer Biol Ther2008;7:1182-90 PMCID:PMC2639623

[57]

Wallace DC.A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.Annu Rev Genet2005;39:359-407 PMCID:PMC2821041

[58]

Chen C,Guan MX.A peep into mitochondrial disorder: multifaceted from mitochondrial DNA mutations to nuclear gene modulation.Protein Cell2015;6:862-70 PMCID:PMC4656216

[59]

Cassim S,Dehbidi-Assadzadeh L,Bilodeau M.Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment.Cell Cycle2018;

[60]

Comerford SA,Du X,Cai L,Walters H,Fu A,Horton JD,McKnight SL.Acetate dependence of tumors.Cell2014;159:1591-602 PMCID:PMC4272450

[61]

Mato JM.Role of S-adenosyl-L-methionine in liver health and injury.Hepatology2007;45:1306-12

[62]

Mato JM,Lu SC.S-adenosylmethionine metabolism and liver disease.Ann Hepatol2013;12:183-9 PMCID:PMC4027041

[63]

Tohme S,Liu Y,van der Windt DJ,Simmons RL,Tai S.Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth through HMGB1 and TLR9 interaction.Hepatology2017;66:182-97

[64]

Zhang C,Huang T,Dai D,Sui X,Chen Y,Huang C,Wang K.Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma.Oncotarget2016;7:81255-67 PMCID:PMC5348390

[65]

Malik AN.Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction?.Mitochondrion2013;13:481-92

[66]

Singh KK,Still I,Geradts J.Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis.Gene2005;354:140-6

[67]

Ye C,Cao Q,Wang Y,Lu J,Li L.Whole-genome DNA methylation and hydroxymethylation profiling for HBV-related hepatocellular carcinoma.Int J Oncol2016;49:589-602

[68]

Wu YL,Peng XE,Zheng DL,Lin X.Epigenetic silencing of NAD(P)H:quinone oxidoreductase 1 by hepatitis B virus X protein increases mitochondrial injury and cellular susceptibility to oxidative stress in hepatoma cells.Free Radic Biol Med2013;65:632-44

[69]

Mizukami S,Watanabe Y,Jin M,Shibutani M.Identification of epigenetically downregulated Tmem70 and Ube2e2 in rat liver after 28-day treatment with hepatocarcinogenic thioacetamide showing gene product downregulation in hepatocellular preneoplastic and neoplastic lesions produced by tumor promotion.Toxicol Lett2017;266:13-22

[70]

Hejzlarova K,Vrbacka-Cizkova A,Hartmannova H,Noskova L,Buzkova J,Zeman J,Houstek J.Expression and processing of the TMEM70 protein.Biochim Biophys Acta2011;1807:144-9

[71]

Havlickova Karbanova V,Hejzlarova K,Stranecky V,Kmoch S.Compensatory upregulation of respiratory chain complexes III and IV in isolated deficiency of ATP synthase due to TMEM70 mutation.Biochim Biophys Acta2012;1817:1037-43

[72]

Shah ZH,Miller SC,Friedman TB.Chromosomal locations of three human nuclear genes (RPSM12, TUFM, and AFG3L1) specifying putative components of the mitochondrial gene expression apparatus.Genomics1998;48:384-8

[73]

Jin D,Mao D,Wang Y,Zhang S.Mitochondria-localized glutamic acid-rich protein (MGARP) gene transcription is regulated by Sp1.PLoS One2012;7:e50053 PMCID:PMC3507827

[74]

Shahbazian MD.Functions of site-specific histone acetylation and deacetylation.Annu Rev Biochem2007;76:75-100

[75]

Bannister AJ,Kouzarides T.Histone methylation: dynamic or static?.Cell2002;109:801-6

[76]

Minocherhomji S,Singh KK.Mitochondrial regulation of epigenetics and its role in human diseases.Epigenetics2012;7:326-34 PMCID:PMC3368816

[77]

Hayami S,Cho HS,Unoki M,Field HI,Yamaue H,Nakamura Y.Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers.Int J Cancer2011;128:574-86

[78]

Sakamoto A,Nagaoka K,Takase R,Ojima H,Arita K.Lysine demethylase LSD1 coordinates glycolytic and mitochondrial metabolism in hepatocellular carcinoma cells.Cancer Res2015;75:1445-56

[79]

Gailhouste L,Ochiya T.Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer.Front Biosci (Landmark Ed)2013;18:199-223

[80]

Burchard J,Liu AM,Lee NP,Sham PC,Ferguson MD,Smith R,Beard R,Lim L,Dai H.microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma.Mol Syst Biol2010;6:402 PMCID:PMC2950084

[81]

Bandiera S,Baumert TF.miR-122--a key factor and therapeutic target in liver disease.J Hepatol2015;62:448-57

[82]

Tsai WC,Hsu CS,Chen SJ,Huang Y,Lee CH,Hsu MT,Huang HD,Hsiao M.MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis.J Clin Invest2012;122:2884-97 PMCID:PMC3408747

[83]

Rayner KJ,Hussain FN,Marshall SM,Ray TD,Goedeke L,Khatsenko OG,Lees CJ,Fisher EA,Moore KJ.Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.Nature2011;478:404-7 PMCID:PMC3235584

[84]

Davalos A,Smibert P,Warrier NP,Cirera-Salinas D,Suresh U,Esplugues E,Penalva LO,Suarez Y,Fernandez-Hernando C.miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling.Proc Natl Acad Sci U S A2011;108:9232-7 PMCID:PMC3107310

[85]

Qiao L,Mao Z,Nie Z,Huang-Yang Y,Liang X,Jiang P.Mitochondrial DNA depletion, mitochondrial mutations and high TFAM expression in hepatocellular carcinoma.Oncotarget2017;8:84373-83 PMCID:PMC5663603

[86]

Machida K.Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?.Hepatol Int2017;11:143-7 PMCID:PMC5759320

[87]

Chen CL,Punj V,Sher L,Hess S.NANOG metabolically reprograms tumor-initiating stem-like cells through tumorigenic changes in oxidative phosphorylation and fatty acid metabolism.Cell Metab2016;23:206-19 PMCID:PMC4715587

[88]

Machida K.Pluripotency transcription factors and metabolic reprogramming of mitochondria in tumor-initiating stem-like cells.Antioxid Redox Signal2017;

[89]

Lee WT.The control of mitochondrial DNA replication during development and tumorigenesis.Ann N Y Acad Sci2015;1350:95-106

[90]

Yamada S,Fujii T,Takeda S,Kanazumi N.Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma.Eur J Surg Oncol2006;32:303-7

[91]

Shen F,Qi JH,Huang JT,Feng YQ,Liu SM.Association of 5-methylcytosine and 5-hydroxymethylcytosine with mitochondrial DNA content and clinical and biochemical parameters in hepatocellular carcinoma.PLoS One2013;8:e76967 PMCID:PMC3797098

[92]

Xie CH,Mizumachi T,Douglas MG,Fan CY.Mitochondrial regulation of cancer associated nuclear DNA methylation.Biochem Biophys Res Commun2007;364:656-61 PMCID:PMC2443723

[93]

Boix L,Rhodes AC.Restoring miR122 in human stem-like hepatocarcinoma cells, prompts tumor dormancy through Smad-independent TGF-beta pathway.Oncotarget2016;7:71309-29 PMCID:PMC5342080

[94]

Omata M,Tateishi R,Lin SM,Kudo M,Choi BI,Shiina S,Jia JD,Han KH,Chow P,Chawla YK,Gani RA,Putranto TA,Sarin SK.Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Hepatol Int2010;4:439-74 PMCID:PMC2900561

[95]

Lou J,Lv S,Jiang S.Biomarkers for hepatocellular carcinoma.Biomark Cancer2017;9:1-9

[96]

Berridge MV,Neuzil J.Mitochondrial DNA in tumor initiation, progression, and metastasis: role of horizontal mtDNA transfer.Cancer Res2015;75:3203-8

[97]

Pasquier J,Al Thawadi H,Maleki M,Jacob A,Galas L,Le Foll F.Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance.J Transl Med2013;11:94 PMCID:PMC3668949

[98]

Chatterjee A,Sidransky D.Mitochondrial subversion in cancer.Cancer Prev Res (Phila)2011;4:638-54 PMCID:PMC3298745

[99]

Chu MP,Venner CP,Hewitt J,Pilarski LM.Addressing heterogeneity of individual blood cancers: the need for single cell analysis.Cell Biol Toxicol2017;33:83-97

[100]

Wang W,Wang X.Can single-cell RNA sequencing crack the mystery of cells?.Cell Biol Toxicol2018;34:1-6

[101]

Wang W.Single-cell CRISPR screening in drug resistance.Cell Biol Toxicol2017;33:207-10

[102]

Qian M,Wang X.Approach, application, and bioethics of mtDNA sequencing in cancer.Adv Exp Med Biol2017;1038:23-38

[103]

Kutay H,Datta J,Pogribny I,Jacob ST.Downregulation of miR-122 in the rodent and human hepatocellular carcinomas.J Cell Biochem2006;99:671-8 PMCID:PMC3033198

[104]

Thakral S.miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir.Curr Gene Ther2015;15:142-50 PMCID:PMC4439190

PDF

136

Accesses

0

Citation

Detail

Sections
Recommended

/